Thioredoxin-1 promotes survival in cells exposed to S-nitrosoglutathione: Correlation with reduction of intracellular levels of nitrosothiols and up-regulation of the ERK1/2 MAP Kinases

Toxicology and Applied Pharmacology

Volumn 233, Issue 2, 2008, Pages 227-237

  Arai, Roberto J ^a   Ogata, Fernando T ^a   Batista, Wagner L ^a   Masutani, Hiroshi ^b   Yodoi, Junji ^b   Debbas, Victor ^a   Augusto, Ohara ^c   Stern, Arnold ^d   Monteiro, Hugo P ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ERK1 2 MAP kinases; Nitric oxide; Nitrosothiol; Nitrotyrosine; p21Ras; Thioredoxin

Indexed keywords

3 NITROTYROSINE; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRITE; S NITROSOGLUTATHIONE; STRESS ACTIVATED PROTEIN KINASE; THIOREDOXIN 1;

ARTICLE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HELA CELL; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; PROTEIN EXPRESSION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

CASPASE 3; CELL DEATH; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NITRITES; PHOSPHORYLATION; S-NITROSOGLUTATHIONE; S-NITROSOTHIOLS; SIGNAL TRANSDUCTION; THIOREDOXINS; TYROSINE; UP-REGULATION;

EID: 56049084898     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.07.023     Document Type: Article

References (74)

1. Arai R.J., Masutani H., Yodoi J., Debbas V., Laurindo F.R., Stern A., and Monteiro H.P. Nitric oxide induces thioredoxin-1 nuclear translocation: possible association with the p21Ras survival pathway. Biochem. Biophys. Res. Commun. 348 (2006) 1254-1260
2. Aulak K.S., Koeck T., Crabb J.W., and Stuehr D.J. Dynamics of protein nitration in cells and mitochondria. Am. J. Physiol. Heart. Circ. Physiol. 286 (2004) H30-H38
3. Bai J., Nakamura H., Kwon Y.W., Hattori I., Yamaguchi Y., Kim Y.C., Kondo N., Oka S., Ueda S., Masutani H., and Yodoi J. Critical roles of thioredoxin in nerve growth factor-mediated signal transduction and neurite outgrowth in PC12 cells. J. Neurosci. 23 (2003) 503-509
4. Batista W.L., Barros T.F., Goldman G.H., Morais F.V., and Puccia R. Identification of transcription elements in the 5' intergenic region shared by LON and MDJ1 heat shock genes from the human pathogen Paracoccidioides brasiliensis. Evaluation of gene expression. Fungal Genet Biol. 44 (2007) 347-356
5. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1620-1624
6. Beer S.M., Taylor E.R., Brown S.E., Dahm C.C., Costa N.J., Runswick M.J., and Murphy M.P. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant defense. J. Biol. Chem. 279 (2004) 47939-47951
7. Benhar M., and Stamler J.S. A central role for S-nitrosylation in apoptosis. Nat. Cell. Biol. 7 (2005) 645-646
8. Benhar M., Forrester M.T., Hess D.T., and Stamler J.S. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 320 (2008) 1050-1054
9. Bryan N.S., Rassaf T., Maloney R.E., Rodriguez C.M., Saijo M., Rodriguez J.R., and Feelisch M. Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4308-4313
10. Callsen D., and Brune B. Role of mitogen-activated protein kinases in S-nitrosoglutathione-induced macrophage apoptosis. Biochemistry 8 (1999) 2279-2286
11. Dahm C.C., Moore K., and Murphy M.P. Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria. J. Biol. Chem. 281 (2006) 10056-10065
12. Eu J.P., Liu L., Seng M., and Stamler J.S. An apoptotic model for nitrosative stress. Biochemistry 39 (2000) 1040-1047
13. Feelisch M., Rassaf T., Mnaimneh S., Singh N., Bryan N.S., Jourd'heuil D., and Kelm M. Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: Implications for the fate of NO in vivo. FASEB J. 16 (2002) 1775-1785
14. Ferret P.J., Soum E., Negre O., Wollman E.E., and Fradelizi D. Protective effect of thioredoxin upon NO-mediated cell injury in THP1 monocytic human cells. Biochem. J. 346 (2000) 759-765
15. Gao J., Liu X., and Rigas B. Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 17207-17212
16. Grune T., Blasig I.E., Sitte N., Roloff B., Haseloff R., and Davies K.J. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. J. Biol. Chem. 273 (1998) 10857-10862
17. Haendeler J., Hoffmann J., Tischler V., Berk B.C., Zeiher A.M., and Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat. Cell. Biol. 10 (2002) 743-749
18. Hansen J.M., Watson W.H., and Jones D.P. Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol. Sci. 82 (2004) 308-317
19. Hess D.T., Matsumoto A., Kim S.O., Marshall H.E., and Stamler J.S. Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell. Biol. 6 (2005) 150-166
20. Hirota K., Matsui M., Iwata S., Nishiyama A., Mori K., and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 3633-3638
21. Hirota K., Murata M., Sachi Y., Nakamura H., Takeuchi J., Mori K., and Yodoi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J. Biol. Chem. 274 (1999) 27891-27897
22. Hirota K., Nakamura H., Masutani H., and Yodoi J. Thioredoxin superfamily and thioredoxin-inducing agents. Ann. N. Y. Acad. Sci. 957 (2002) 189-199
23. Hirst D.G., and Robson T. Nitrosative stress in cancer therapy. Front. Biosci. 12 (2007) 3406-3418
24. Irie Y., Saeki M., Kamisaki Y., Martin E., and Murad F. Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 5634-5639
25. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. 356 (1998) 1-11
26. Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem. Biophys. Res. Commun. 30 (2003) 776-783
27. Jaiswal A.K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 36 (2004) 1199-1207
28. Jarry A., Charrier L., Bou-Hanna C., Devilder M.C., Crussaire V., Denis M.G., Vallette G., and Laboisse C.L. Position in cell cycle controls the sensitivity of colon cancer cells to nitric oxide-dependent programmed cell death. Cancer Res. 64 (2004) 4227-4234
29. Kahlos K., Zhang J., Block E.R., and Patel J.M. Thioredoxin restores nitri-oxide-induced inhibition of protein kinase C activity in lung endothelial cells. Mol. Cell Biochem. 245 (2003) 47-54
30. Kim P.K., Zamora R., Petrosko P., and Billiar T.R. The regulatory role of nitric oxide in apoptosis. Int. Immunopharmacol. 8 (2001) 1421-1441
31. Kim Y.C., Masutani H., Yamaguchi Y., Itoh K., Yamamoto M., and Yodoi J. Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. J. Biol. Chem. 276 (2001) 18399-18406
32. Kim S.J., Miyoshi Y., Taguchi T., Tamaki Y., Nakamura H., Yodoi J., Kato K., and Noguchi S. High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer. Clin. Cancer. Res. 11 (2005) 8425-8430
33. Kissner R., Nauser T., Bugnar P., Lye P.G., and Koppenol W.H. Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis. Chem. Res. Toxicol. 10 (1997) 1285-1292
34. Lander H.M., Hajjar D.P., Hempstead B.L., Mirza U.A., Chait B.T., Campbell S., and Quilliam L.A. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J. Biol. Chem. 272 (1997) 4323-4326
35. Lee J.Y., Huerta-Yepez S., Vega M., Baritaki S., Spandidos D.A., and Bonavida B. The NO TRAIL to YES TRAIL in cancer therapy. Int J Oncol. 31 (2007) 685-691
36. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]Ct method. Methods. 25 (2001) 402-408
37. MacMillan-Crow L.A., Greendorfer J.S., Vickers S.M., and Thompson J.A. Tyrosine nitration of c-SRC tyrosine kinase in human pancreatic ductal adenocarcinoma. Arch. Biochem. Biophys. 377 (2000) 350-356
38. Marshall H.E., and Stamler J.S. Nitrosative stress-induced apoptosis through inhibition of NF-kappa B. J. Biol. Chem. 277 (2002) 34223-34228
39. Masumoto H., Kissner R., Koppenol W.H., and Sies H. Kinetic study of the reaction of ebselen with peroxynitrite. FEBS Lett. 398 (1996) 179-182
40. Masutani H., Hirota H., Sasada T., Ueda-Taniguchi Y., Taniguchi Y., Sono H., and Yodoi J. Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I Tax. Immunol. Lett. 54 (1996) 67-71
41. Millet A., Bettaieb A., Renaud F., Prevotat L., Hammann A., Solary E., Mignotte B., and Jeannin J.F. Influence of the nitric oxide donor glyceryl trinitrate on apoptotic pathways in human colon cancer cells. Gastroenterology 123 (2002) 235-246
42. Mitchell D.A., Morton S.U., Fernhoff N.B., and Marletta M.A. Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 11609-11614
43. Mocellin S., Bronte V., and Nitti D. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med. Res. Rev. 27 (2007) 317-352
44. Monteiro H.P. Signal transduction by protein tyrosine nitration: Competition or cooperation with tyrosine phosphorylation-dependent signaling events?. Free Radic. Biol. Med. 33 (2002) 765-773
45. Monteiro H.P., Rocha Oliveira C.J., Curcio M.F., Moraes M.S., and Arai R.J. Tyrosine phosphorylation in nitric oxide-mediated signaling events. Methods Enzymol. 396 (2005) 350-358
46. Monteiro H.P., Arai R.J., and Travassos L.R. Protein tyrosine phosphorylation and protein tyrosine nitration in redox signaling. Antiox Redox Signal. 10 (2008) 843-890
47. Nakamura H., Nakamura K., and Yodoi J. Redox regulation of cellular activation. Annu Rev. Immunol. 15 (1997) 351-369
48. Nakamura H., Herzenberg L.A., Bai J., Araya S., Kondo N., Nishinaka Y., Herzenberg L.A., and Yodoi J. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc. Natl. Acad. Sci. U. S. A. 26 (2001) 15143-15148
49. Nikitovic D., and Holmgren A. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J. Biol. Chem., 271 (1996) 19180-19185
50. Nikitovic D., Holmgren A., and Spirou G. Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos. Biochem. Biophys. Res. Commun. 242 (1998) 109-112
51. Ohshima H., Tatemichi M., and Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch. Biochem. Biophys. 423 (2004) 12-22
52. Park H.S., Huh S.H., Kim M.S., Lee S.H., and Choi E.J. Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 14382-14387
53. Pervin S., Singh R., Freije W.A., and Chaudhuri G. MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer. Cancer Res. 63 (2003) 8853-8860
54. Pesse B., Levrand S., Feihl F., Waeber B., Gavillet B., Pacher P., and Liaudet L. Peroxynitrite activates ERK via Raf-1 and MEK, independently from EGF receptor and p21Ras in H9C2 cardiomyocytes. J. Mol. Cell. Cardiol. 38 (2005) 765-775
55. Pinzar E., Wang T., Garrido M.R., Xu W., Levy P., and Bottari S.P. Angiotensin II induces tyrosine nitration and activation of ERK1/2 in vascular smooth muscle cells. FEBS Lett. 579 (2005) 100-104
56. Powis G., and Montfort W.R. Properties and biological activities of thioredoxins. Annu. Rev. Biophys. Biomol. Struct. 30 (2001) 421-455
57. Radi R., Peluffo G., Alvarez M.N., Naviliat M., and Cayota A. Unraveling peroxynitrite formation in biological systems. Free Radic. Biol. Med. 30 (2001) 463-488
58. Raffel J., Bhattacharyya A.K., Gallegos A., Cui H., Einspahr J.G., Alberts D.S., and Powis G. Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival. J. Lab. Clin. Med. 142 (2003) 46-51
59. Rocha Oliveira C.J., Schindler F., Ventura A.M., Morais M.S., Arai R.J., Debbas V., Stern A., and Monteiro H.P. Nitric oxide and cGMP activate the Ras-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells. Free Radic. Biol Med. 35 (2003) 381-396
60. Souza J.M., Choi I., Chen Q., Weisse M., Daikhin E., Yudkoff M., Obin M., Ara J., Horwitz J., and Ischiropoulos H. Proteolytic degradation of tyrosine nitrated proteins. Arch. Biochem. Biophys. 380 (2000) 360-366
61. Stoyanovsky D.A., Tyurina Y.Y., Tyurin V.A., Anand D., Mandavia D.N., Gius D., Ivanova J., Pitt B., Billiar T.R., and Kagan V.E. Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitrosothiols. J. Am. Chem. Soc. 127 (2005) 15815-15823
62. Sumbayev V.V., and Yasinska I.M. Regulation of MAP kinase-dependent apoptotic pathway: implication of reactive oxygen and nitrogen species. Arch. Biochem. Biophys. 436 (2005) 406-412
63. Tao L., Gao E., Bryan N.S., Qu Y., Liu H.R., Hu A., Christopher T.A., Lopez B.L., Yodoi J., Koch W.J., Feelisch M., and Ma X.L. Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11471-11476
64. Tao L., Jiao X., Gao E., Lau W.B., Yuan Y., Lopez B., Christopher T., Ramachandra Rao S.P., Williams W., Southan G., Sharma K., Koch W., and Ma X.L. Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circulation 114 (2006) 1395-1402
65. Tsujita M., Batista W.L., Ogata F., Stern A., Monteiro H.P., and Arai R.J. The nitric oxide-sensitive p21Ras-ERK pathway mediates S-nitrosoglutathione-induced apoptosis. Biochem. Biophys Res. Commun. 369 (2008) 1001-1006
66. Ueno M., Masutani H., Arai R.J., Yamauchi A., Hirota K., Sakai T., Inamoto T., Yamaoka Y., Yodoi J., and Nikaido T. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem. 274 (1999) 35809-35815
67. Ullrich V., and Kissner R. Redox signaling: bioinorganic chemistry at its best. J. Inorg. Biochem. 100 (2006) 2079-2086
68. Vojtek A.B., and Der C.J. Increasing complexity of the Ras signaling pathway. J. Biol. Chem. 273 (1998) 19925-19928
69. Watson W.H., Yang X., Choi Y.E., Jones D.P., and Kehrer J.P. Thioredoxin and its role in toxicology. Toxicol. Sci. 78 (2003) 3-14
70. Wink D.A., Cook J.A., Kim S.Y., Vodovotz Y., Pacelli R., Krishna M.C., Russo A., Mitchell J.B., Jourd'heuil D., Miles A.M., and Grisham M.B. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J. Biol. Chem. 272 (1997) 11147-11151
71. Yokomizo A., Ono M., Nanri H., Makino Y., Ohga T., Wada M., Okamoto T., Yodoi J., Kuwano M., and Kohno K. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res. 55 (1995) 4293-4296
72. Zeng H., Spencer N.Y., and Hogg N. Metabolism of S-nitrosoglutathione by endothelial cells. Am. J. Physiol. Heart. Circ. Physiol. 281 (2001) H432-H439
73. Zhang J., Velsor L.M., Patel J.M., Postlethwait E.M., and Block E.R. Nitric oxide-induced reduction of lung cell and whole lung thioredoxin expression is regulated by NF-kappaB. Am. J. Physiol. 277 (1999) 787-793
74. Zhang Y., and Hogg N. The mechanism of transmembrane S-nitrosothiol transport. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7891-7896